Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy (NCT07521462) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy
50 participantsStarted 2026-09-01
Plain-language summary
The aim of this clinical study is to evaluate the effectiveness and safety of a dermocosmetic product in reducing facial redness and visible blood vessels associated with erythematotelangiectatic rosacea.
Investigators will compare the dermocosmetic product to a placebo applied to opposite sides of the face, when used alone and in combination with laser treatment.
Participants will apply the products twice daily for 2 month followed by continued use in combination with laser treatment, and will attend regular clinical visits for assessments and questionnaires.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Gender: male or female
* Age: \> 18 years -Patients with mild to severe erythro-couperotic rosacea (stage 2, 3, or 4 - TRoSA scale, section 2.2.3.1)
* Patients wishing to undergo vascular laser treatments for their rosacea
* Patients who have provided informed consent
Exclusion Criteria:
* Pregnant patients or patients with a positive urine pregnancy test at the initial visit
* Patients with another condition in the study area.
* Patients who have received laser treatment for the same condition within the previous 12 months.
* Patients with another form of rosacea (e.g., papules and pustules, ocular rosacea, etc.).
* Patients using another anti-redness product on the face during the study.
* Patients who have taken photosensitizing treatments during the month prior to study enrollment.
* Patients taking or having taken oral isotretinoin within 6 months prior to study enrollment.
* Patients enrolled in another study.
* Adult patients under a legal guardianship arrangement (guardianship, conservatorship, judicial protection).
* Patients not covered by social security.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Efficacy of the dermocosmetic product
Timeframe: From enrollment to the end of treatment at 8 months